Literature DB >> 14960346

Glial cell line-derived neurotrophic factor is essential for neuronal survival in the locus coeruleus-hippocampal noradrenergic pathway.

E M Quintero1, L M Willis, V Zaman, J Lee, H A Boger, A Tomac, B J Hoffer, I Strömberg, A-C Granholm.   

Abstract

It has been shown that the noradrenergic (NE) locus coeruleus (LC)-hippocampal pathway plays an important role in learning and memory processing, and that the development of this transmitter pathway is influenced by neurotrophic factors. Although some of these factors have been discovered, the regulatory mechanisms for this developmental event have not been fully elucidated. Glial cell line-derived neurotrophic factor (GDNF) is a potent neurotrophic factor influencing LC-NE neurons. We have utilized a GDNF knockout animal model to explore its function on the LC-NE transmitter system during development, particularly with respect to target innervation. By transplanting various combinations of brainstem (including LC) and hippocampal tissues from wildtype or GDNF knockout fetuses into the brains of adult wildtype mice, we demonstrate that normal postnatal development of brainstem LC-NE neurons is disrupted as a result of the GDNF null mutation. Tyrosine hydroxylase immunohistochemistry revealed that brainstem grafts had markedly reduced number and size of LC neurons in transplants from knockout fetuses. NE fiber innervation into the hippocampal co-transplant from an adjacent brainstem graft was also influenced by the presence of GDNF, with a significantly more robust innervation observed in transplants from wildtype fetuses. The most successful LC/hippocampal co-grafts were generated from fetuses expressing the wildtype GDNF background, whereas the most severely affected transplants were derived from double transplants from null-mutated fetuses. Our data suggest that development of the NE LC-hippocampal pathway is dependent on the presence of GDNF, most likely through a target-derived neurotrophic function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14960346     DOI: 10.1016/j.neuroscience.2003.11.001

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  5 in total

1.  The differential effects of pathway- versus target-derived glial cell line-derived neurotrophic factor on peripheral nerve regeneration.

Authors:  Christina K Magill; Amy M Moore; Ying Yan; Alice Y Tong; Matthew R MacEwan; Andrew Yee; Ayato Hayashi; Daniel A Hunter; Wilson Z Ray; Philip J Johnson; Alexander Parsadanian; Terence M Myckatyn; Susan E Mackinnon
Journal:  J Neurosurg       Date:  2010-07       Impact factor: 5.115

2.  Development of amyloid burden in African Green monkeys.

Authors:  Sergey Kalinin; Stephanie L Willard; Carol A Shively; Jay R Kaplan; Thomas C Register; Matthew J Jorgensen; Paul E Polak; Israel Rubinstein; Douglas L Feinstein
Journal:  Neurobiol Aging       Date:  2013-04-18       Impact factor: 4.673

3.  Necroptosis in Niemann-Pick disease, type C1: a potential therapeutic target.

Authors:  A Cougnoux; C Cluzeau; S Mitra; R Li; I Williams; K Burkert; X Xu; C A Wassif; W Zheng; F D Porter
Journal:  Cell Death Dis       Date:  2016-03-17       Impact factor: 8.469

4.  Impaired Latent Inhibition in GDNF-Deficient Mice Exposed to Chronic Stress.

Authors:  Mona Buhusi; Colten K Brown; Catalin V Buhusi
Journal:  Front Behav Neurosci       Date:  2017-10-10       Impact factor: 3.558

Review 5.  Genetic contributions to the etiology of anorexia nervosa: New perspectives in molecular diagnosis and treatment.

Authors:  Stefano Paolacci; Aysha Karim Kiani; Elena Manara; Tommaso Beccari; Maria Rachele Ceccarini; Liborio Stuppia; Pietro Chiurazzi; Laura Dalla Ragione; Matteo Bertelli
Journal:  Mol Genet Genomic Med       Date:  2020-05-05       Impact factor: 2.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.